TOKYO -- Japanese chemical company Teijin has invested in an American venture developing a device for treating infections after prosthetic joint implant surgery, aiming to cooperate in research and commercialization.
Health Care
Japan's Teijin invests in U.S. medical device startup
Garwood seeking to treat infections after prosthetic joint implant surgery
Teijin has invested in the developer of a device to combat infections in prosthetic joint implants. (Photo by Satoko Kawasaki)
Read Next
Latest on Health Care
